Impact of glycemic control on survival of diabetic patients on chronic regular nemodialysis - A 7-year observational study

被引:132
作者
Oomichi, Takeshi
Emoto, Masanori
Tabata, Tsutomu
Morioka, Tomoaki
Tsujimoto, Yoshihiro
Tahara, Hideki
Shoji, Tetsuo
Nishizawa, Yoshiki
机构
[1] Osaka City Univ, Grad Sch Med, Dept Internal Med, Div Metab Endocrinol & Mol Med, Osaka 5458585, Japan
[2] Inoue Hosp, Dept Internal Med, Suita, Osaka, Japan
关键词
D O I
10.2337/dc05-1887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To investigate the impact of glycemic control during regular hemodialysis on the survival of diabetic patients with chronic kidney disease (CKD) in a longitudinal observational study. RESEARCH DESIGN AND METHODS - A total of 114 diabetic CKD patients on hemodialysis at Inoue Hospital (Suita, Japan) were surveyed from May 1995 to December 2002 (survey period 45.5 +/- 29.3 [means +/- SD] months). All subjects were categorized into three groups by mean HbA(1c) (A1C) level during the 3-month period on hemodialysis preceding entry, as follows: good (A1C < 6.5%, 5.7 +/- 0.4%, n = 34), fair (6.5 <= A1C < 8.0%, 7.2 +/- 0.4%, n 39), and poor (A1C = 8.0%, 9.2 +/- 0.9%, n = 41) A1C groups. RESULTS - There were no significant differences in age at entry, initiation of hemodialysis, duration of hemodialysis, blood pressure, carchothoracic ratio, serum creatinine level, or hemoglobin level among the three groups. The cumulative survival of the poor A1C group during the survey was significantly lower than that of the fair and good A1C groups as determined by Kaplan-Meier estimation (P = 0.041, log-rank test). In a multivariate Cox proportional hazard model, both poor A1C group (hazard ratio 2.889, P = 0.010) and mean A1C (1.260 per 1.0%, P = 0.003) were significant predictors of survival. CONCLUSIONS - In diabetic CKD patients on regular hemodialysis, poor glycemic control is an independent predictor of prognosis. This finding indicates the importance of careful management of glycemic control even after initiation of hemodialysis.
引用
收藏
页码:1496 / 1500
页数:5
相关论文
共 17 条
[1]   Assessing glycemic control in patients with diabetes and end-stage renal failure [J].
Ansari, A ;
Thomas, S ;
Goldsmith, D .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) :523-531
[2]   Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial [J].
Chiasson, JL ;
Josse, RG ;
Gomis, R ;
Hanefeld, M ;
Karasik, A ;
Laakso, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (04) :486-494
[3]   Cardiovascular disease in end-stage renal disease patients [J].
Collins, AJ ;
Li, SL ;
Ma, JZ ;
Herzog, C .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :S26-S29
[4]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[5]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[6]   Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease [J].
Manske, CL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S157-S171
[7]   Diabetes education and care management significantly improve patient outcomes in the dialysis unit [J].
McMurray, SD ;
Johnson, G ;
Davis, S ;
McDougall, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (03) :566-575
[8]   Minority advantage in diabetic end-stage renal disease survival on hemodialysis: Due to different proportions of diabetic type? [J].
Medina, RA ;
Pugh, JA ;
Monterrosa, A ;
Cornell, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (02) :226-234
[9]   Glycemic control is a predictor of survival for diabetic patients on hemodialysis [J].
Morioka, T ;
Emoto, M ;
Tabata, T ;
Shoji, T ;
Tahara, H ;
Kishimoto, H ;
Ishimura, E ;
Nishizawa, Y .
DIABETES CARE, 2001, 24 (05) :909-913
[10]  
Nathan DM, 2003, NEW ENGL J MED, V348, P761